Directive 2001/20/EC
E1537266
UNEXPLORED
Directive 2001/20/EC was an EU legislative act that established the original regulatory framework for the conduct of clinical trials on medicinal products for human use within the European Union.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Directive 2001/20/EC canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22404623 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Directive 2001/20/EC Context triple: [Regulation (EU) No 536/2014, repeals, Directive 2001/20/EC]
-
A.
Directive 2001/104/EC
Directive 2001/104/EC is a European Union legislative act that updates and refines the regulatory framework for medical devices originally established by Council Directive 93/42/EEC.
-
B.
Directive 2001/82/EC
Directive 2001/82/EC is a key European Union law that sets out the rules for the authorization, supervision, and pharmacovigilance of veterinary medicinal products across EU member states.
-
C.
Directive 2000/70/EC
Directive 2000/70/EC is a European Union legislative act that updated and strengthened the regulatory framework for medical devices, particularly those incorporating stable derivatives of human blood or human plasma, within the scope of Council Directive 93/42/EEC.
-
D.
Council Directive 2001/86/EC
Council Directive 2001/86/EC is a European Union legal act that supplements the Statute for a European Company (Societas Europaea) by establishing rules on employee involvement in such companies.
-
E.
Directive 2002/98/EC
Directive 2002/98/EC is a European Union law that sets quality and safety standards for the collection, testing, processing, storage, and distribution of human blood and blood components for transfusion.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Directive 2001/20/EC Target entity description: Directive 2001/20/EC was an EU legislative act that established the original regulatory framework for the conduct of clinical trials on medicinal products for human use within the European Union.
-
A.
Directive 2001/104/EC
Directive 2001/104/EC is a European Union legislative act that updates and refines the regulatory framework for medical devices originally established by Council Directive 93/42/EEC.
-
B.
Directive 2001/82/EC
Directive 2001/82/EC is a key European Union law that sets out the rules for the authorization, supervision, and pharmacovigilance of veterinary medicinal products across EU member states.
-
C.
Directive 2000/70/EC
Directive 2000/70/EC is a European Union legislative act that updated and strengthened the regulatory framework for medical devices, particularly those incorporating stable derivatives of human blood or human plasma, within the scope of Council Directive 93/42/EEC.
-
D.
Council Directive 2001/86/EC
Council Directive 2001/86/EC is a European Union legal act that supplements the Statute for a European Company (Societas Europaea) by establishing rules on employee involvement in such companies.
-
E.
Directive 2002/98/EC
Directive 2002/98/EC is a European Union law that sets quality and safety standards for the collection, testing, processing, storage, and distribution of human blood and blood components for transfusion.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.